Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Comment on "Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors" (Arch Orthop Trauma Surg. 2010 Jul; 130(7):819-27).

Wolff R, Westwood M, Paschen U, Sauerland S, Kleijnen J.

Arch Orthop Trauma Surg. 2012 Aug;132(8):1217-8. doi: 10.1007/s00402-012-1530-7. Epub 2012 May 27. No abstract available.

PMID:
22643802
2.

Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors.

Bischoff M, Bischoff G, Buck A, von Baer A, Pauls S, Scheffold F, Schultheiss M, Gebhard F, Reske SN.

Arch Orthop Trauma Surg. 2010 Jul;130(7):819-27. doi: 10.1007/s00402-009-0937-2. Epub 2009 Jul 28.

PMID:
19636577
3.

PET/CT in primary musculoskeletal tumours: a step forward.

Lakkaraju A, Patel CN, Bradley KM, Scarsbrook AF.

Eur Radiol. 2010 Dec;20(12):2959-72. doi: 10.1007/s00330-010-1862-z. Epub 2010 Jun 25. Review.

PMID:
20577880
4.

F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.

Iagaru A, Quon A, McDougall IR, Gambhir SS.

Clin Nucl Med. 2006 Dec;31(12):754-60.

PMID:
17117068
5.

Subcutaneous and intramuscular metastases of cervix cancer detected with ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography after the chemoradiation therapy.

Tamam MO, Mulazimoglu M, Aydin T.

Rev Esp Med Nucl Imagen Mol. 2013 Mar;32(2):128-9. doi: 10.1016/j.remn.2012.04.008. Epub 2012 Jun 1. No abstract available.

6.

Carbon-11 choline positron emission tomography in musculoskeletal tumors: comparison with fluorine-18 fluorodeoxyglucose positron emission tomography.

Yanagawa T, Watanabe H, Inoue T, Ahmed AR, Tomiyoshi K, Shinozaki T, Oriuchi N, Endo K, Takagishi K.

J Comput Assist Tomogr. 2003 Mar-Apr;27(2):175-82.

PMID:
12703009
7.

F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions.

Wiesenthal AA, Nguyen BD.

Clin Nucl Med. 2007 Oct;32(10):797-801.

PMID:
17885362
8.

Multiple leiomyosarcoma foci in 18F-FDG PET-CT.

Sürücü E, Aslan M, Karahan P, Durak H.

Rev Esp Med Nucl Imagen Mol. 2013 Jul-Aug;32(4):269-70. doi: 10.1016/j.remn.2012.08.002. Epub 2012 Oct 31. No abstract available.

9.
10.

FDG PET/CT findings in primary hyperparathyroidism mimicking multiple bone metastases.

Demir H, Halac M, Gorur GD, Sonmezoglu K, Uslu I.

Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):686. Epub 2007 Dec 11. No abstract available.

PMID:
18071699
11.

Isolated facial muscle metastasis from renal cell carcinoma on F-18 FDG PET/CT.

Kang S, Song BI, Lee HJ, Jeong SY, Seo JH, Lee SW, Ahn BC, Lee J, Lee HJ.

Clin Nucl Med. 2010 Apr;35(4):263-4. doi: 10.1097/RLU.0b013e3181d18f37. No abstract available.

PMID:
20305417
12.

PET-CT demonstration of extensive muscle metastases from breast cancer.

Liu Y, Ghesani N, Mirani N, Zuckier LS.

Clin Nucl Med. 2006 May;31(5):266-8. No abstract available.

PMID:
16622333
13.

Interesting image. Maffucci syndrome with extraosseous chondrosarcoma imaged with F-18 FDG PET-CT.

Makis W, Hickeson M, Lisbona R.

Clin Nucl Med. 2010 Jan;35(1):29-31. doi: 10.1097/RLU.0b013e3181c36160. No abstract available.

PMID:
20026970
14.

A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.

Qu X, Huang X, Yan W, Wu L, Dai K.

Eur J Radiol. 2012 May;81(5):1007-15. doi: 10.1016/j.ejrad.2011.01.126. Epub 2011 Feb 26. Review.

PMID:
21354739
15.

Increased F-18 FDG uptake on positron emission tomography/computed tomography imaging caused by plantar fibromatosis.

Scheler J, Rehani B, Percy T, Pelstring R, Bharija A, Ames D, Mantil J.

Clin Nucl Med. 2008 Apr;33(4):280-1. doi: 10.1097/RLU.0b013e3181662b69.

PMID:
18356670
16.

Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET.

Basu S, Torigian D, Alavi A.

Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):465-71. No abstract available.

PMID:
17955239
17.

Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.

Tateishi U, Hosono A, Makimoto A, Nakamoto Y, Kaneta T, Fukuda H, Murakami K, Terauchi T, Suga T, Inoue T, Kim EE.

Ann Nucl Med. 2009 Feb;23(2):155-61. doi: 10.1007/s12149-008-0219-z. Epub 2009 Feb 19.

PMID:
19225939
18.

Recognition of fibrous dysplasia of bone mimicking skeletal metastasis on 18F-FDG PET/CT imaging.

Su MG, Tian R, Fan QP, Tian Y, Li FL, Li L, Kuang AR, Miller JH.

Skeletal Radiol. 2011 Mar;40(3):295-302. doi: 10.1007/s00256-010-0999-9. Epub 2010 Aug 2.

PMID:
20680622
19.

18F-FDG PET/CT compared to conventional imaging modalities in pediatric primary bone tumors.

London K, Stege C, Cross S, Onikul E, Graf N, Kaspers G, Dalla-Pozza L, Howman-Giles R.

Pediatr Radiol. 2012 Apr;42(4):418-30. doi: 10.1007/s00247-011-2278-x. Epub 2011 Dec 2.

PMID:
22134535
20.

Magnetic resonance/positron emission tomography (MR/PET) oncologic applications: bone and soft tissue sarcoma.

Partovi S, Chalian M, Fergus N, Kosmas C, Zipp L, Mansoori B, Ros PR, Robbin MR.

Semin Roentgenol. 2014 Oct;49(4):345-52. doi: 10.1053/j.ro.2014.04.004. Epub 2014 Apr 13. Review. No abstract available.

PMID:
25498231

Supplemental Content

Support Center